US 6630464
Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer
expired A61KA61K31/433A61K31/549
Quick answer
US patent 6630464 (Cyclin dependent kinase (CDK)4 inhibitors and their use for treating cancer) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 07 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/433, A61K31/549, A61P, A61P35/00